Press Release: WILLOW BIOSCIENCES ANNOUNCES ANNUAL GENERAL AND SPECIAL MEETING VOTING RESULTS

Dow Jones
26 Apr

WILLOW BIOSCIENCES ANNOUNCES ANNUAL GENERAL AND SPECIAL MEETING VOTING RESULTS

PR Newswire

SUNNYVALE, Calif., April 25, 2025

SUNNYVALE, Calif., April 25, 2025 /PRNewswire/ - Willow Biosciences Inc. ("Willow" or the "Company") (TSX: WLLW) (OTCQB: CANSF) is pleased to announce the voting results from its annual general and special meeting of shareholders held on April 25, 2025 (the "Meeting"). A total of 59,214,893 common shares, representing approximately 40.88% of the Company's issued and outstanding shares were represented at the meeting.

The shareholders approved the setting of the number of directors of Willow at 5 directors, and the following nominees were elected as directors of Willow for the ensuing year with the specific voting results being as follows:

 
                       Votes For        Votes Withheld 
-----------------  ------------------  ----------------- 
Director               #         %         #        % 
-----------------  ----------  ------  ---------  ------ 
Dr. Chris Savile   46,902,346  88.3 %  6,234,676  11.7 % 
-----------------  ----------  ------  ---------  ------ 
Dr. Jim Lalonde    46,965,380  88.4 %  6,171,642  11.6 % 
-----------------  ----------  ------  ---------  ------ 
Donald Archibald   44,900,287  84.5 %  8,236,735  15.5 % 
-----------------  ----------  ------  ---------  ------ 
Raffi Asadorian    46,963,057  88.4 %  6,173,965  11.6 % 
-----------------  ----------  ------  ---------  ------ 
Al Foreman         46,900,723  88.3 %  6,236,299  11.7 % 
-----------------  ----------  ------  ---------  ------ 
 

In addition, shareholders approved the below matters. The resolutions approving the below matters may be viewed in full in the Company's management information circular dated March 26, 2025 (the "Information Circular").

 
                                                                Votes For 
----------------------------------------------------------  ------------------ 
Director                                                        #         % 
----------------------------------------------------------  ----------  ------ 
Appointment of KPMG LLP as the Company's auditor for the 
 ensuring year                                              51,882,364  87.6 % 
----------------------------------------------------------  ----------  ------ 
The proposed sale of the shares of Epimeron USA, Inc., the 
 Corporation's wholly-owned subsidiary, as more 
 particularly described in the Information Circular         46,996,397  88.4 % 
----------------------------------------------------------  ----------  ------ 
To authorize the Corporation's board of directors, at its 
 sole discretion, to amend the Articles of the Corporation 
 to change its name from "Willow Biosciences Inc." to 
 "2482118 Alberta Ltd.", or such other name as may be 
 approved by the Board, as more particularly described in 
 the Information Circular.                                  48,853,362  82.5 % 
----------------------------------------------------------  ----------  ------ 
 

For complete voting results on all matters approved at the Meeting, please see the Company's Report of Voting Results dated April 25, 2025, available on SEDAR+ at www.sedarplus.ca.

About Willow Biosciences Inc.

Willow develops and produces precision fermented functional ingredients for the health and wellness, food and beverage and personal care markets. Willow's FutureGrown$(TM)$ biotechnology platform allows large-scale production with sustainability at its core. Willow's R&D team has a proven track record of developing and commercializing bio-based manufacturing processes and products to benefit our B2B partners and their customers.

For more information, visit www.willowbio.com or contact:

Travis Doupe

Chief Financial Officer

E: info@willowbio.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/willow-biosciences-announces-annual-general-and-special-meeting-voting-results-302438831.html

SOURCE Willow Biosciences Inc.

 

(END) Dow Jones Newswires

April 25, 2025 19:22 ET (23:22 GMT)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10